Why is Oxygenta Pharma falling/rising?

As of 09-Oct, Oxygenta Pharmaceutical Ltd's stock price is currently at Rs. 61.32, reflecting a decline of Rs. 3.22 or 4.99%. The stock has hit a new 52-week low today and has been on a downward trend, experiencing a consecutive fall over the last three days with a total decline of 12.02%. Additionally, the stock has underperformed its sector by 5.93%. In terms of returns, Oxygenta has seen significant declines over various periods, including a 9.81% drop over the past week and a 17.24% decrease over the past month, while year-to-date returns stand at a negative 29.90%. The stock is also trading below all key moving averages, indicating a bearish trend. There is a notable increase in investor participation, with delivery volume rising by 198.4% compared to the 5-day average, suggesting some interest despite the falling price. In the broader market context, Oxygenta's recent performance contrasts sharply with the Sensex, which has gained 1.47% over the past week and 1.32% over the past month. This disparity highlights the stock's struggles relative to the overall market, as it has significantly underperformed the benchmark. The negative sentiment surrounding Oxygenta is further compounded by its substantial year-to-date decline compared to the Sensex's positive return of 5.16%. Overall, the combination of poor stock performance, underwhelming returns, and the stock's position below key moving averages contributes to the ongoing decline in Oxygenta's stock price.